Lawmakers express need to balance 'innovation and affordability'published at 15:35 BST 24 September 2024 Now Republican Senator Bill Cassidy says there are "serious questions" about the high costs of these drugs in the US compared to abroad, but says he also doesn't want to hinder pharmaceutical innovation
This concentration is rarely used for long-term treatment because patients outgrow it quickly during dose escalation
We know, in 2024, [about] a quarter of people with type 2 diabetes were on GLP-1s, soobviously, people taking them for type 2 diabetes are different from people just taking them for weight loss
This means a single 10mg vial can theoretically cover the first 12 to 13 weeks of a standard escalation protocol, using roughly 7mg through that period
Medicare and Medicaid If you have Medicare, it usually doesnt cover semaglutide for weight loss
2023 is the accessible mechanistic comparison of tirzepatide and semaglutide and is worth reading alongside Willard for the signaling-bias piece